Rani Therapeutics Holdings (RANI) FCF Margin (QoQ) (2020 - 2026)

Rani Therapeutics Holdings (RANI) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.29 Bn	78.30 Bn	3.93 Bn
3	Argenx Se	65.17 Bn	59.98 Bn	1.37 Bn
4	Moderna	61.38 Bn	56.24 Bn	52.00 Mn
5	BeOne Medicines	42.18 Bn	37.09 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.99 Bn	27.68 Bn	992.69 Mn
7	BioNTech SE	28.45 Bn	10.05 Bn	668.28 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Rani Therapeutics Holdings	163.02 Mn	163.02 Mn	-

Download Data